Skip to main content
logo
Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
44.54
+5.67 (14.59%)
Nov 6, 2026, 2:13 PM EST - Market open

Edgewise Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,8762,6272,528694565753
Market Cap Growth
167.18%3.91%264.15%22.85%-24.97%-
Enterprise Value
3,1362,0682,040410203463
Last Close Price
38.8724.8226.7010.948.9415.28

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.615.035.512.181.632.75
P/TBV Ratio
3.025.035.512.181.632.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.010.020.01-
Net Debt / Equity Ratio
-1.07-1.01-1.01-0.98-1.00-1.02
Net Debt / EBITDA Ratio
-1.542.782.972.774.886.54
Net Debt / FCF Ratio
8.613.654.223.205.978.22
Quick Ratio
12.1019.3719.7018.9921.2226.69
Current Ratio
12.3019.8519.9319.5021.5326.97
Return on Equity (ROE)
92.14%-34.19%-34.40%-30.10%-21.78%-21.34%
Return on Assets (ROA)
59.76%-23.02%-24.01%-20.21%-13.73%-12.97%
Return on Capital Employed (ROCE)
69.10%-36.40%-34.30%-35.40%-20.40%-15.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
19.50%-6.39%-5.29%-14.43%-11.97%-5.68%
FCF Yield
-4.11%-5.48%-4.36%-14.07%-10.29%-4.54%
Buyback Yield / Dilution
-16.12%-11.38%-45.02%-18.90%-42.82%-4977.96%
SEC Filings: 10-K · 10-Q